Human corticotropin-releasing hormone improves overnight FEV1 in nocturnal asthma

George Georges, Monica Kraft, Elcio O. Vianna, Richard J. Martin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Corticotropin-releasing hormone (CRH) exhibits anti-inflammatory properties independent of its effect on adrenal function. We investigated the safety and effect of CRH in nocturnal asthma, a disease where inflammation is prominent. Five subjects underwent an overnight infusion of placebo on the first night, CRH at a 2.5 μg/kg/hr on the second night, and three subjects received CRH at 4.0 μg/kg/hr on the third night. A significant improvement occurred in overnight change in forced expiratory volume at 1 sec. % (ΔFEV1) with CRH (+17.4 ± 9.1%) as opposed to placebo (-25.9 ± 7.1%), p = 0.024. CRH was well tolerated. Further research with CRH may clarify the pathophysiology of nocturnal asthma.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalJournal of Asthma
Volume35
Issue number3
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Asthma
Placebos
Forced Expiratory Volume
Anti-Inflammatory Agents
Inflammation
Safety
Research

Keywords

  • Corticotropin-releasing hormone
  • Inflammation
  • Nocturnal asthma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Human corticotropin-releasing hormone improves overnight FEV1 in nocturnal asthma. / Georges, George; Kraft, Monica; Vianna, Elcio O.; Martin, Richard J.

In: Journal of Asthma, Vol. 35, No. 3, 01.01.1998, p. 261-265.

Research output: Contribution to journalArticle

Georges, George ; Kraft, Monica ; Vianna, Elcio O. ; Martin, Richard J. / Human corticotropin-releasing hormone improves overnight FEV1 in nocturnal asthma. In: Journal of Asthma. 1998 ; Vol. 35, No. 3. pp. 261-265.
@article{0b56b23a55da4f009243a597e25f3af9,
title = "Human corticotropin-releasing hormone improves overnight FEV1 in nocturnal asthma",
abstract = "Corticotropin-releasing hormone (CRH) exhibits anti-inflammatory properties independent of its effect on adrenal function. We investigated the safety and effect of CRH in nocturnal asthma, a disease where inflammation is prominent. Five subjects underwent an overnight infusion of placebo on the first night, CRH at a 2.5 μg/kg/hr on the second night, and three subjects received CRH at 4.0 μg/kg/hr on the third night. A significant improvement occurred in overnight change in forced expiratory volume at 1 sec. {\%} (ΔFEV1) with CRH (+17.4 ± 9.1{\%}) as opposed to placebo (-25.9 ± 7.1{\%}), p = 0.024. CRH was well tolerated. Further research with CRH may clarify the pathophysiology of nocturnal asthma.",
keywords = "Corticotropin-releasing hormone, Inflammation, Nocturnal asthma",
author = "George Georges and Monica Kraft and Vianna, {Elcio O.} and Martin, {Richard J.}",
year = "1998",
month = "1",
day = "1",
doi = "10.3109/02770909809068216",
language = "English (US)",
volume = "35",
pages = "261--265",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Human corticotropin-releasing hormone improves overnight FEV1 in nocturnal asthma

AU - Georges, George

AU - Kraft, Monica

AU - Vianna, Elcio O.

AU - Martin, Richard J.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Corticotropin-releasing hormone (CRH) exhibits anti-inflammatory properties independent of its effect on adrenal function. We investigated the safety and effect of CRH in nocturnal asthma, a disease where inflammation is prominent. Five subjects underwent an overnight infusion of placebo on the first night, CRH at a 2.5 μg/kg/hr on the second night, and three subjects received CRH at 4.0 μg/kg/hr on the third night. A significant improvement occurred in overnight change in forced expiratory volume at 1 sec. % (ΔFEV1) with CRH (+17.4 ± 9.1%) as opposed to placebo (-25.9 ± 7.1%), p = 0.024. CRH was well tolerated. Further research with CRH may clarify the pathophysiology of nocturnal asthma.

AB - Corticotropin-releasing hormone (CRH) exhibits anti-inflammatory properties independent of its effect on adrenal function. We investigated the safety and effect of CRH in nocturnal asthma, a disease where inflammation is prominent. Five subjects underwent an overnight infusion of placebo on the first night, CRH at a 2.5 μg/kg/hr on the second night, and three subjects received CRH at 4.0 μg/kg/hr on the third night. A significant improvement occurred in overnight change in forced expiratory volume at 1 sec. % (ΔFEV1) with CRH (+17.4 ± 9.1%) as opposed to placebo (-25.9 ± 7.1%), p = 0.024. CRH was well tolerated. Further research with CRH may clarify the pathophysiology of nocturnal asthma.

KW - Corticotropin-releasing hormone

KW - Inflammation

KW - Nocturnal asthma

UR - http://www.scopus.com/inward/record.url?scp=0031824192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031824192&partnerID=8YFLogxK

U2 - 10.3109/02770909809068216

DO - 10.3109/02770909809068216

M3 - Article

C2 - 9661678

AN - SCOPUS:0031824192

VL - 35

SP - 261

EP - 265

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 3

ER -